Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Female × Caloric Restriction × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 10 Obesity 6 Weight Loss 5 Overweight 3 Menstruation Disturbances 2 Intermittent Fasting 2 Insulin Resistance 2 Tumor Surgery 1 Obesity, Abdominal 1 Motor Activity 1 Metabolic Syndrome 1 Metabolic Diseases 1 Infertility 1 Glucocorticoid Receptor Deficiency 1 Fasting 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Breast Cancer Female 1 Body Weight 1

Interventions

Tamoxifen 3 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1 Saline Solution 1 Ropivacaine 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03131024 2024-09-19

CREATE

University of Alberta

Phase NA Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡